DaVita Inc. logo
DaVita Inc. (DVA)
Compare

DVA Financials

SEC Filings

DVA Quarterly Income Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
13.835B3.416B3.620B3.420B3.380B3.224B3.295B3.264B3.187B
Cost of Goods Sold
9.533B2.342B2.596B2.333B2.262B2.240B2.225B2.152B2.142B
4.302B1.073B1.024B1.087B1.118B983.869M1.069B1.112B1.044B
31.4%31.4%28.3%31.8%33.1%30.5%32.5%34.1%32.8%
Total Operating Expenses
2.226B591.399M472.362M581.701M580.145M544.932M503.950M576.837M538.025M
0.000.000.000.000.000.000.000.000.00
1.721B421.914M472.362M414.373M412.805M374.090M414.482M393.534M367.845M
2.077B481.892M551.205M505.767M537.841M438.937M565.362M534.878M506.398M
14.1%14.1%15.2%14.8%15.9%13.6%17.2%16.4%15.9%
1.402B341.234M382.759M308.803M368.928M286.333M413.733M373.434M371.440M
Interest Income
559.750M145.131M118.000M150.557M146.062M135.055M138.721M134.583M97.747M
Other Income/Expense
-674.981M-140.658M-168.446M-196.964M-168.913M-152.604M-151.629M-161.444M-134.958M
781.416M197.530M234.217M150.332M199.337M162.917M259.329M214.688M222.676M
305.189M66.199M76.728M68.554M93.708M54.117M64.488M77.674M71.688M
5.8%5.8%6.5%4.4%5.9%5.1%7.9%6.6%7.0%
2.700B655.248M717.714M636.850M689.694M597.839M726.556M695.031M644.848M
19.2%19.2%19.8%18.6%20.4%18.5%22.1%21.3%20.2%
716.726M177.829M186.703M177.490M174.704M176.451M174.102M187.014M175.661M
10.152.932.512.092.622.053.182.562.56
9.942.872.452.042.582.003.092.502.50
67.390M67.390M86.100M72.075M75.943M79.368M81.620M83.721M86.899M
68.875M68.875M88.100M73.769M77.362M81.275M83.854M85.795M88.950M

DVA Annual Income Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
13.643B12.816B12.140B11.610B11.619B11.551B11.388B11.405B
Cost of Goods Sold
9.959B8.599B8.320B8.210B7.972B7.989B7.914B8.196B
3.684B4.217B3.820B3.400B3.646B3.562B3.474B3.209B
27.0%32.9%31.5%29.3%31.4%30.8%30.5%28.1%
Total Operating Expenses
1.674B2.127B2.218B2.061B1.849B1.867B1.831B1.684B
0.000.000.000.000.000.000.000.00
1.674B1.538B1.474B1.355B1.195B1.248B1.103B1.135B
2.011B2.090B1.603B1.339B1.797B1.695B1.643B1.526B
14.7%16.3%13.2%11.5%15.5%14.7%14.4%13.4%
1.347B1.530B1.177B966.278M1.518B1.318B1.195B1.048B
Interest Income
549.674M470.469M398.551M357.019M285.254M304.111M443.824M487.435M
Other Income/Expense
-663.792M-560.090M-425.690M-372.784M-278.876M-376.374M-447.878M-477.346M
746.803M936.342M691.535M560.400M978.450M773.642M810.981M159.394M
293.107M279.656M220.116M198.087M306.732M313.932M279.628M258.400M
5.5%7.3%5.7%4.8%8.4%6.7%7.1%1.4%
2.642B2.725B2.321B2.056B2.484B2.253B2.254B2.127B
19.4%21.3%19.1%17.7%21.4%19.5%19.8%18.6%
715.348M723.860M745.443M732.602M680.615M630.435M615.152M591.035M
9.7211.027.625.889.306.545.294.63
9.5110.737.425.718.906.395.274.58
86.100M84.991M90.790M92.992M105.230M119.797M153.181M170.786M
88.100M87.274M93.182M95.834M109.948M122.623M153.812M172.365M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Denver, CO
76,000 employees
Healthcare / Medical - Care Facilities
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Javier J. Rodriguez